-
-
-
-
-
-
-
Stifel on COMPASS Pathways plc (CMPS): 'COMP360 continues to be well-tolerated'
-
-
-
-
-
-
-
B.Riley Reiterates Buy Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Raised to $21 at Stifel
-
-
-
-
-
-
-
TD Cowen on Compass Pathways (CMPS) Amid +10% Gain Today: 'e continue to model '360 approval in 1H27'
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) Tops Q1 EPS by 13c
-
-
-
-
-
-
-
B.Riley Starts Compass Pathways (CMPS) at Buy
-
-
-
-
-
-
-
BTIG on Compass Pathways (CMPS): 'COMP360 is shaping up as clinically meaningful'
-
479,046 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


